Compare Eaton Corporation plc (ETN) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eaton Corporation plc vs Neurocrine Biosciences Inc — how do they compare? Eaton Corporation plc trades at $472.18 (market cap $172.82B), while Neurocrine Biosciences Inc trades at $158 (market cap $16.46B). The key difference: Eaton Corporation plc is far larger — about 10.5× Neurocrine Biosciences Inc's market cap, and Eaton Corporation plc pays a 0.99% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| ETN | NBIX | |
|---|---|---|
Market Cap | $172.82B | $16.46B |
Sector | Technology | Health |
52-Week High | $459.29 | $185.50 |
52-Week Low | $315.82 | $123.10 |
Enterprise Value | $193.45B | $16.48B |
Dividend Yield | 0.99% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eaton Corporation plc
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
